{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:42:58Z","timestamp":1789371778042,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,4,27]],"date-time":"2014-04-27T00:00:00Z","timestamp":1398556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00432-014-1687-2","type":"journal-article","created":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T11:03:59Z","timestamp":1398510239000},"page":"1441-1449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage I non-small cell lung cancer"],"prefix":"10.1007","volume":"140","author":[{"given":"Jun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baosen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueshan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,27]]},"reference":[{"key":"1687_CR1","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1200\/JCO.2008.18.1081","volume":"26","author":"B Besse","year":"2008","unstructured":"Besse B, Chevalier TL (2008) Adjuvant chemotherapy for non\u2013small-cell lung cancer: a fading effect? JCO 26:5014\u20135017","journal-title":"JCO"},{"key":"1687_CR2","first-page":"17","volume":"26","author":"S Carl-McGrath","year":"2005","unstructured":"Carl-McGrath S, Lendeckel U, Ebert M, Roessner A, R\u00f6cken C (2005) The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer. Int J Oncol 26:17\u201324","journal-title":"Int J Oncol"},{"issue":"1","key":"1687_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1200\/JCO.2009.25.5109","volume":"28","author":"JY Douillard","year":"2010","unstructured":"Douillard JY, Gauducheau CR (2010) Adjuvant chemotherapy for non-small-cell lung cancer: it does not always fade with time. JCO 28(1):3\u20135","journal-title":"JCO"},{"key":"1687_CR4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1172\/JCI7497","volume":"105","author":"AD Everett","year":"2000","unstructured":"Everett AD, Lobe DR, Matsumura ME, Nakamura H, McNamara CA (2000) Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development. J Clin Invest 105:567\u2013575","journal-title":"J Clin Invest"},{"key":"1687_CR5","doi-asserted-by":"crossref","first-page":"L1194","DOI":"10.1152\/ajplung.00427.2003","volume":"286","author":"AD Everett","year":"2004","unstructured":"Everett AD, Narron JV, Stoops T, Nakamura H, Tucker A (2004) Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor. Am J Physiol Lung Cell Mol Physiol 286:L1194\u2013L1201","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1687_CR6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.eururo.2007.11.034","volume":"54","author":"FR Fritzsche","year":"2008","unstructured":"Fritzsche FR, Jung M, T\u00f6lle A et al (2008a) ADAM9 Expression is a significant and independent prognostic marker of PSA relapse in prostate cancer. Eur Urol 54:1097\u20131106","journal-title":"Eur Urol"},{"key":"1687_CR7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1471-2407-8-179","volume":"8","author":"FR Fritzsche","year":"2008","unstructured":"Fritzsche FR, Wassermann K, Jung M et al (2008b) ADAM9 is highly expression in renal cell cancer and is associated with tumour progression. BMC Cancer 8:179","journal-title":"BMC Cancer"},{"key":"1687_CR8","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/sj.bjc.6601645","volume":"90","author":"R Grutzmann","year":"2004","unstructured":"Grutzmann R, Luttges J, Sipos B et al (2004) ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma. Br J Cancer 90:1053\u20131058","journal-title":"Br J Cancer"},{"key":"1687_CR9","first-page":"1075","volume":"13","author":"T Iwasaki","year":"2005","unstructured":"Iwasaki T, Nakaqawa K, Nakamura H, Takada Y, Matsui K, Kawahara K (2005) Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer. Oncol Rep 13:1075\u20131080","journal-title":"Oncol Rep"},{"key":"1687_CR10","first-page":"77","volume":"42","author":"Q Liu","year":"2013","unstructured":"Liu Q, Zhang J (2013) Abnormal expression of GLO1 in non-small cell lung cancer. Zhongguo Yike Daxue Xuebao 42:77\u201378 (In Chinese)","journal-title":"Zhongguo Yike Daxue Xuebao"},{"key":"1687_CR11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","volume":"83","author":"JR Molina","year":"2008","unstructured":"Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA (2008) Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83:584\u2013594","journal-title":"Mayo Clin Proc"},{"key":"1687_CR12","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1378\/chest.111.6.1710","volume":"111","author":"CF Mountain","year":"1997","unstructured":"Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111:1710\u20131717","journal-title":"Chest"},{"key":"1687_CR13","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0003-4975(95)00169-L","volume":"60","author":"JC Nesbitt","year":"1995","unstructured":"Nesbitt JC, Putnam JB Jr, Walsh GL, Roth JA, Mountain CF (1995) Survival in early-stage non-small cell lung cancer. Ann Thorac Surg 60:466\u2013472","journal-title":"Ann Thorac Surg"},{"key":"1687_CR14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/ijc.11161","volume":"105","author":"C O\u2019Shea","year":"2003","unstructured":"O\u2019Shea C, Mckie N, Buggy Y et al (2003) Expression of ADAM9m RNA and protein in human breast cancer. Int J Cancer 105:754\u2013761","journal-title":"Int J Cancer"},{"key":"1687_CR15","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1200\/JCO.2004.02.080","volume":"22","author":"H Ren","year":"2004","unstructured":"Ren H, Tang X, Lee JJ et al (2004) Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer. JCO 22:3230\u20133237","journal-title":"JCO"},{"key":"1687_CR16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11\u201330","journal-title":"CA Cancer J Clin"},{"key":"1687_CR17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/path.1420","volume":"201","author":"A Tannapfel","year":"2003","unstructured":"Tannapfel A, Anhalt K, Hausermann P et al (2003) Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays. J Pathol 201:238\u2013249","journal-title":"J Pathol"},{"key":"1687_CR18","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1158\/1078-0432.CCR-06-1064","volume":"12","author":"H Uyama","year":"2006","unstructured":"Uyama H, Tomita Y, Nakamura H et al (2006) Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer. Clin Cancer Res 12:6043\u20136048","journal-title":"Clin Cancer Res"},{"key":"1687_CR19","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/S0959-8049(01)00271-4","volume":"37","author":"A Wimmel","year":"2001","unstructured":"Wimmel A, Glitz D, Kraus A, Roeder J, Schuermann M (2001) Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion. Eur J Cancer 37:2264\u20132274","journal-title":"Eur J Cancer"},{"key":"1687_CR20","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1200\/JCO.2010.31.0144","volume":"28","author":"Y Xie","year":"2010","unstructured":"Xie Y, Minna JD (2010) Non-small-cell lung cancer mRNA expression signature predicting response to adjuvant chemotherapy. JCO 28:4404\u20134407","journal-title":"JCO"},{"key":"1687_CR21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1158\/1078-0432.CCR-05-1347","volume":"12","author":"S Yamamoto","year":"2006","unstructured":"Yamamoto S, Tomita Y, Hoshida Y et al (2006) Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma. Clin Cancer Res 12:117\u2013122","journal-title":"Clin Cancer Res"},{"key":"1687_CR22","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1245\/s10434-007-9369-9","volume":"14","author":"S Yamamoto","year":"2007","unstructured":"Yamamoto S, Tomita Y, Hoshida Y et al (2007) Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma. Ann Surg Oncol 14:2141\u20132149","journal-title":"Ann Surg Oncol"},{"key":"1687_CR23","unstructured":"Zhang J, Mao L (2006) SiRNA targeting hepatoma-derived growth factor (HDGF) inhibits growth of non-small cell lung cancer in xenograft models. Tumor Biology 35: Emerging Molecules, Mechanisms, and Models. Proc Amer Assoc Cancer Res 47:abstract #5135"},{"key":"1687_CR24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1158\/0008-5472.CAN-04-3905","volume":"66","author":"J Zhang","year":"2006","unstructured":"Zhang J, Ren H, Yuan P, Lang W, Zhang L, Mao L (2006) Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells. Cancer Res 66:18\u201323","journal-title":"Cancer Res"},{"key":"1687_CR25","first-page":"211","volume":"14","author":"J Zhang","year":"2011","unstructured":"Zhang J, Qi J, Guo Y et al (2011a) Aberrant expression of HDGF and its prognostic values in surgically resected non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 14:211\u2013218 (In Chinese)","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"1687_CR26","first-page":"280","volume":"40","author":"J Zhang","year":"2011","unstructured":"Zhang J, Qi J, Guo Y (2011b) Abnormal expression and clinical significance of HDGF and ADAM9 in non-small cell lung cancer. Zhongguo Yike Daxue Xuebao 40:280\u2013281 (In Chinese)","journal-title":"Zhongguo Yike Daxue Xuebao"},{"key":"1687_CR27","doi-asserted-by":"crossref","first-page":"s1068","DOI":"10.1097\/JTO.0b013e318208eb35","volume":"6","author":"J Zhang","year":"2011","unstructured":"Zhang J, Qi J, Chen N, Guo Y, Fu W, Zhou B, He A (2011c) Highly expressed ADAM9 in completed resected stage I non-small cell lung cancer cases predicts a shortened survival. J Thorac Oncol 6:s1068\u2013s1069","journal-title":"J Thorac Oncol"},{"key":"1687_CR28","doi-asserted-by":"crossref","first-page":"s753","DOI":"10.1097\/JTO.0b013e31828b51f5","volume":"8","author":"J Zhang","year":"2013","unstructured":"Zhang J, Chen N, Qi J (2013a) HDGF, ADAM9 involved in a novel pathway of cell growth and invasion of non-small cell lung cancer cells, may become novel molecular staging biomarkers, prognostic and predictive biomarkers of NSCLC. J Thorac Oncol 8:s753","journal-title":"J Thorac Oncol"},{"key":"1687_CR29","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3892\/ol.2013.1209","volume":"5","author":"J Zhang","year":"2013","unstructured":"Zhang J, Qi J, Chen N, Fu W, Zhou B, He A (2013b) High expression of a disintegrin and metalloproteinase-9 predicts a shortened survival time in completely resected stage I non-small cell lung cancer. Oncol Lett 5:1461\u20131466","journal-title":"Oncol Lett"},{"key":"1687_CR30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1746-1596-5-58","volume":"5","author":"Y Zhou","year":"2010","unstructured":"Zhou Y, Zhou N, Fang W, Huo J (2010) Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer. Diagn Pathol 5:58","journal-title":"Diagn Pathol"},{"key":"1687_CR31","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1200\/JCO.2009.26.4325","volume":"28","author":"CQ Zhu","year":"2010","unstructured":"Zhu CQ, Ding K, Strumpf F et al (2010) Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. JCO 28:4417\u20134424","journal-title":"JCO"},{"key":"1687_CR32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ygyno.2009.05.005","volume":"114","author":"A Zubel","year":"2009","unstructured":"Zubel A, Flechtenmacher C, Edler L, Alonso A (2009) Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix. Gynecol Oncol 114:332\u2013336","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1687-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-014-1687-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1687-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T18:43:15Z","timestamp":1565376195000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-014-1687-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,27]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["1687"],"URL":"https:\/\/doi.org\/10.1007\/s00432-014-1687-2","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,27]]}}}